| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/03/2007 | WO2007048856A1 Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imaging |
| 05/03/2007 | WO2007048830A2 Assays for histone deacetylase 1/2 selective inhibitors |
| 05/03/2007 | WO2007048821A2 Fitting for holding a probe |
| 05/03/2007 | WO2007048785A2 Apparatus for the analysis of a sample on a test element |
| 05/03/2007 | WO2007048617A1 In vitro method for diagnosing neurodegenerative diseases |
| 05/03/2007 | WO2007048436A1 Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof |
| 05/03/2007 | WO2007048415A1 Methods and uses for detection of invasiveness of tumors |
| 05/03/2007 | WO2007048187A1 Methods and apparatus for measuring properties of fibre samples |
| 05/03/2007 | WO2007033318A3 Continuous spectroscopic measurement of total hemoglobin |
| 05/03/2007 | WO2007030949A3 Methods of diagnosing ovarian cancer and kits therefor |
| 05/03/2007 | WO2007030928A3 Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites |
| 05/03/2007 | WO2007030206A3 Method and apparatus for gas measurement at substantially constant pressure |
| 05/03/2007 | WO2007028655A3 Drug discovery for neurodevelopmental disorders and their complications |
| 05/03/2007 | WO2007026171A3 Vdcc gamma-8 ion channel |
| 05/03/2007 | WO2007025781A3 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 05/03/2007 | WO2007024678A3 Scintillation proximity assay for the identification of p-glycoprotein modulators |
| 05/03/2007 | WO2007021628A9 Target and assay for lead compounds for polycystic kidney disease |
| 05/03/2007 | WO2007020405A3 Integrin i-domain binding peptides |
| 05/03/2007 | WO2007019276A3 Quantitative detection of lead in water |
| 05/03/2007 | WO2007014244A3 Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile |
| 05/03/2007 | WO2007012982A3 Normalization of complex analyte mixtures |
| 05/03/2007 | WO2007011941A3 Human anti-b7rp1 neutralizing antibodies |
| 05/03/2007 | WO2007010240A3 Method for high-throughput screening |
| 05/03/2007 | WO2007008064A3 Device and method for separating analysing, detecting and/or determining? particles in a liquid sample flow |
| 05/03/2007 | WO2007007185A3 Assay |
| 05/03/2007 | WO2007002574A3 Cspcna isoform modifications and uses thereof |
| 05/03/2007 | WO2006138647A3 Method of making recombinant human antibodies for use in biosensor technology |
| 05/03/2007 | WO2006138340A3 Method and apparatus for the non-invasive sensing of glucose in a human subject |
| 05/03/2007 | WO2006137933A3 Microbubbles for affinity separation |
| 05/03/2007 | WO2006125124A3 Substrate functionalization method for high sensitivity applications |
| 05/03/2007 | WO2006112878A3 Apparatus and method for providing a fluid cut measurement of a multi-liquid mixture compensated for entrained gas |
| 05/03/2007 | WO2006110762A3 Pharmaceutical compositions for and methods of inhibiting hcv replication |
| 05/03/2007 | WO2006099875A8 Antibodies against cd38 for treatment of multiple myeloma |
| 05/03/2007 | WO2006097244A3 Methods for assessing emphysema |
| 05/03/2007 | WO2006074130A3 Microwave accelerated plasmonics |
| 05/03/2007 | WO2006067792A3 Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease |
| 05/03/2007 | WO2006044062A3 Method and apparatus for rapid extraction and analysis, by sers, of drugs in saliva |
| 05/03/2007 | WO2006043179A8 Expression profiling platform technology |
| 05/03/2007 | WO2006039405A3 Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof |
| 05/03/2007 | WO2006036688A9 Gpr43 and modulators thereof for the treatment of metabolic-related disorders |
| 05/03/2007 | WO2006023412A3 Biomarkers for osteoarthritis |
| 05/03/2007 | WO2006019582A3 Methods and devices for rapid analysis of liquids |
| 05/03/2007 | WO2006017140A3 Methods for optically encoding an object with upconverting materials and compositions used therein |
| 05/03/2007 | WO2006012588A3 Methods and devices for diagnosis of appendicitis |
| 05/03/2007 | WO2005072142A3 Hybrid nucleic acid assembly |
| 05/03/2007 | WO2004084820A3 Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients |
| 05/03/2007 | WO2004046685A3 Quality control of assays |
| 05/03/2007 | WO2003052049A3 Molecules for disease detection and treatment |
| 05/03/2007 | US20070101451 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/03/2007 | US20070101450 DNA that encodes a protein having high-affinity choline transporter activity |
| 05/03/2007 | US20070101446 Antibodies against epitopes with homology to self antigens, methods of preparation |
| 05/03/2007 | US20070101443 Animal models; drug screening; uridine diphospho-glucuronosyl transferase; predicting likely behaviour of a drug in a selected species of primate |
| 05/03/2007 | US20070100665 Messaging to remote patients in a networked health-monitoring system |
| 05/03/2007 | US20070100561 Crystals of DPP-IV |
| 05/03/2007 | US20070100559 Crystal structure of a deacetylase and inhibitors thereof |
| 05/03/2007 | US20070100556 System, method and software arrangement utilizing a multi-strip procedure that can be applied to gene characterization using dna-array data |
| 05/03/2007 | US20070099862 Sequence specific gene silencing; antisense agents |
| 05/03/2007 | US20070099857 Methods and means for inhibiting fever |
| 05/03/2007 | US20070099836 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 05/03/2007 | US20070099824 Treatments which Alleviate Functional Glycosylated Leptin Transport Factor, for Controlling Weight and Obesity |
| 05/03/2007 | US20070099307 Ligand concentrating, liquid crystal biosensor system |
| 05/03/2007 | US20070099306 Receptor is coated with an electrically conductive material, contacting the receptor with a sample to be tested, in the presence of a non-conductive medium, when the ligand is present, a receptor-ligand complex is formed |
| 05/03/2007 | US20070099305 Quantitative, high-throughput screening method for protein stability |
| 05/03/2007 | US20070099304 Method for the selective isolation of multiply-charged peptides applicable in the quantitative proteomics |
| 05/03/2007 | US20070099303 Methods for determining the feeding habits of an animal |
| 05/03/2007 | US20070099302 taking baseline reading to determine person's blood pH, administering substance challenge to determine how substance affects person's blood pH, waiting a period of time, retaking the blood ph, determining if the patient's blood has been alkalized or acidified |
| 05/03/2007 | US20070099301 Systems and methods for measuring glycated hemoglobin |
| 05/03/2007 | US20070099271 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 05/03/2007 | US20070099263 Materials and methods relating to g-protein coupled receptor oligomers |
| 05/03/2007 | US20070099260 Use of a Composition which Regulates Oxidation/Reduction Reactions Intracellularly and/or Extracellularly in a Staining or Sorting Process |
| 05/03/2007 | US20070099255 Diagnostics and therapeutics for diseases associated with n-acetylated alpha-linked acidic dipeptidase 2(naaladase 2) |
| 05/03/2007 | US20070099253 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
| 05/03/2007 | US20070099252 Diagnostic application of mail |
| 05/03/2007 | US20070099251 Tissue-and serum-derived glycoproteins and methods of their use |
| 05/03/2007 | US20070099250 Methods for treating proliferative diseases and for monitoring the effectiveness of treatment of proliferative diseases |
| 05/03/2007 | US20070099249 Compositions and liquid crystals |
| 05/03/2007 | US20070099248 Monovalent streptavidin compositions |
| 05/03/2007 | US20070099247 Polypeptide Display Libraries and Methods of Making and Using Thereof |
| 05/03/2007 | US20070099246 Antibodies, assays and kits to quantitate cartilage destruction |
| 05/03/2007 | US20070099245 Assays for neutralizing antibodies |
| 05/03/2007 | US20070099244 Specific binding sites in collagen for integrins and use thereof |
| 05/03/2007 | US20070099243 Method for searching myelin using gonadotropin-releasing hormone receptors as a new biomarker |
| 05/03/2007 | US20070099242 Lipoprotein-associated markers for cardiovascular disease |
| 05/03/2007 | US20070099241 Method of detecting a subfraction of proBNP |
| 05/03/2007 | US20070099240 Pixel arrays |
| 05/03/2007 | US20070099239 Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease |
| 05/03/2007 | US20070099238 Enhancement of emission using metal coated dielectric nanoparticles |
| 05/03/2007 | US20070099235 Method for designing surfaces |
| 05/03/2007 | US20070099234 Specific detection of chitin using chitin-binding domain |
| 05/03/2007 | US20070099233 Cross-reference |
| 05/03/2007 | US20070099232 Ecdysone receptor ligand-binding domain structure |
| 05/03/2007 | US20070099231 Bioelastomer |
| 05/03/2007 | US20070099230 Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecles, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 05/03/2007 | US20070099229 Atherothrombosis risk in an individual is indicated by an FSAP protein concentration that is reduced compared to the FSAP protein concentration in the standard sample |
| 05/03/2007 | US20070099226 determining whether a candidate compound is capable of modulating local intracellular cAMP concentration within a eukaryotic cell; whole-cell patch-clamp technique |
| 05/03/2007 | US20070099221 Method of analyzing nucleic acid |
| 05/03/2007 | US20070099219 Systems and methods for treating, diagnosing and predicting the occurence of a medical condition |
| 05/03/2007 | US20070099217 Method for stress evaluation |
| 05/03/2007 | US20070099215 NOVEL Bak BINDING PROTEIN, DNA ENCODING THE PROTEIN, AND METHODS OF USE THEREOF |
| 05/03/2007 | US20070099214 Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer |